Philips shareholders approve all proposals at the AGM 2024
May 07 2024 - 11:30AM
Philips shareholders approve all proposals at the AGM 2024
May 7, 2024
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,
AEX: PHIA), today announced that its shareholders approved all
proposals at the Annual General Meeting of Shareholders (AGM) 2024,
including:
- The re-appointment of Chairman Feike Sijbesma and Peter Löscher
as members of the Supervisory Board.
- The appointment of Benoît Ribadeau-Dumas as member of the
Supervisory Board.
- The appointment of Charlotte Hanneman as member of the Board of
Management, with effect from October 1, 2024.
- The discharge of the members of the Board of Management and
members of the Supervisory Board.
- A full overview of the resolutions taken at the AGM 2024 can be
found below.
Feike Sijbesma, Chairman of Philips’ Supervisory Board, said: “I
am very pleased with the re-appointment of Peter and the
appointment of Benoît, who has extensive experience with large and
global industrial companies. With our highly knowledgeable and
experienced members, the composition of our Supervisory Board is
very strong and well positioned to fulfill our vital duty of
advising, challenging, and supporting Management in executing
Philips’ strategy, and it is an honor to serve a second term
leading this Board.
I would also like to welcome Charlotte to Philips. She will join
Philips’ Board of Management on October 1, and fulfill the role of
Chief Financial Officer. Her strong MedTech knowledge and
extensive finance experience, coupled with her energy and passion
for the healthcare industry, make her an ideal fit for the role.
Charlotte will work with Abhijit, Philips’ current Chief Financial
Officer, until October, ensuring a smooth transition. I would also
like to thank Abhijit in advance for his tremendous contribution to
Philips over the last 38 years, and more particularly during his
nine years as Chief Financial Officer.”
Roy Jakobs, CEO of Royal Philips said: “I want to congratulate
our Chairman Feike with his re-appointment. Together with Peter and
Benoît, as well as the other Supervisory Board members, they
represent the best in the industry to provide oversight and
valuable insights to Management in executing Philips’ 2023-2025
plan to create value with sustainable impact for all stakeholders.
We look forward to a continued strong and successful collaboration,
as we aim to improve the health and well-being of people through
meaningful innovation.”
All resolutions taken at the AGM 2024:
Agenda item |
Resolution |
2 |
Annual Report 2023
- Adoption of the financial statements 2023
- Adoption of a dividend of EUR 0.85 per common share, in common
shares, against retained earnings
- Positive advisory vote on the approval of the Remuneration
Report 2023
- Discharge of the members of the Board of Management
- Discharge of the members of the Supervisory Board
|
3 |
Composition of the Board of Management
- Appointment of Ms Hanneman as member of the Board of Management
with effect from October 1, 2024
|
4 |
Composition of the Supervisory
Board
- Re-appointment of Mr Sijbesma as member of the Supervisory
Board with effect from May 7, 2024
- Re-appointment Mr Löscher as member of the Supervisory Board
with effect from May 7, 2024
- Appointment of Mr Ribadeau-Dumas as member of the Supervisory
Board with effect from May 7, 2024
|
5 |
Remuneration of the Board of Management and the Supervisory
Board
- Adoption of Remuneration Policy for the Board of
Management
- Adoption of Remuneration Policy for the Supervisory Board
|
6 |
Authorization of the Board of Management to issue shares or
grant rights to acquire shares and restrict or exclude pre-emption
rights |
7 |
Authorization of the Board of Management to acquire shares in
the company |
8 |
Cancellation of shares |
Further details about the dividend can be found via
this link, and additional information on the composition of
the Board of Management, the Executive Committee and the
Supervisory Board can be found here. Philips’ 2023 financial
statements are included in its Annual Report 2023 that was
published on February 20, 2024. For more information about Philips’
AGM 2024, please click on this link.
For further information, please contact:
Elco van GroningenPhilips External RelationsTel.: +31 6 8103
9584E-mail: elco.van.groningen@philips.com
Dorin DanuPhilips Investor RelationsTel.: +31 20 59 77055E-mail:
dorin.danu@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA)
is a leading health technology company focused on improving
people's health and well-being through meaningful innovation.
Philips’ patient- and people-centric innovation leverages advanced
technology and deep clinical and consumer insights to deliver
personal health solutions for consumers and professional health
solutions for healthcare providers and their patients in the
hospital and the home. Headquartered in the Netherlands, the
company is a leader in diagnostic imaging, ultrasound, image-guided
therapy, monitoring, and enterprise informatics, as well as in
personal health. Philips generated 2023 sales of EUR 18.2 billion
and employs approximately 69,100 employees with sales and services
in more than 100 countries. News about Philips can be found
at www.philips.com/newscenter.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Nov 2024 to Dec 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Dec 2023 to Dec 2024